- Hype & Hope Portal
- About Hype & Hope
- Contact Us
- Privacy
- Published by:Zoomedia, Inc.
Join our Mailing List
Feed Hype & Hope updates directly to your favorite news aggregator such as My Yahoo!, NewsGator or FeedDemon.
Published by Zoomedia, Inc.
Zoomedia is a leading communications agency dedicated to increasing our clients' value through insightful and imaginative creative programs for the life sciences industry.
For questions or comments about this site, please contact hypeandhope@zoomedia.com.
©2008 Zoomedia, Inc.
All rights reserved.
California, Here We Come
Long before the most recent showdown between the U.S. Congress and President George W. Bush over the use of embryonic stem cells, the administration’s intransigence drove proponents of the research to take their case to the states. California’s successful passage in 2004 of Proposition 71, which set aside $3 billion in tax dollars to fund stem cell research, quickened the pace of advocacy in various regions, with officials around the country kept awake by visions of the Golden State extending its lead in biotechnology.By inadvertently creating a new grassroots movement to support embryonic stem cell research, the Bush administration actually may have fostered a model that will serve biomedical research more broadly in the future. It has also put many Republicans in a bind. In many parts of the country, biomedical research — and especially embryonic stem cell research...
California, Here We Come
Long before the most recent showdown between the U.S. Congress and President George W. Bush over the use of embryonic stem cells, the administration’s intransigence drove proponents...
Impossible Policy
Imagine a school principal who says he wants to learn how best to incorporate new technologies into the classroom but forbids participation by the most enthusiastic and recently trained...
Staying the Course
I never wanted Zach Hall’s job. Now it appears he doesn’t want it anymore either. The former President of the California Institute for Regenerative Medicine (CIRM) resigned earlier...
Show Me the Money: How Stem Cell Researchers Can Obtain State Funds
Though states historically have taken a back seat to the federal government regarding funding biotech research that is no longer the case. States are aggressively using monies and...
Stem Cell Cures? The Long and Winding Road
Stem cells. We've heard they can cure Parkinson's disease, patch damaged hearts, replace the pancreas, rewire the spinal cord, cure cancer and restore memories lost in the fog of Alzheimer's...
Little Stuff, Little Steps: Adult or Embryonic Stem Cell Research: Which to Fund?
The Stem Cell Research Enhancement Act would allow federal funding for new embryonic stem cell research. It is supported by majorities in the U.S. House of Representatives and the Senate,...
Indian Americans Mobilize at DNC
Indian American Democratic activists, galvanized by new grass-roots campaign strategies, are more eager than ever to mobilize voters around the country, according to Democratic party leader Parag Mehta.
>> Read the StoryStem Cell Therapeutics Corp. Receives Positive Review from Data Safety & Monitoring Board
Stem Cell Therapeutics Corp. has received results from the Data Safety Monitoring Board (DSMB) that provides oversight for the Company's Phase IIb REGENESIS trial. The DSMB has completed a safety analysis and has recommended the trial continue as per the protocol.
>> Read the StorySarah Palin’s Speech: The Good, the Bad, and the Whoops
And so Sarah Palin has made her speech. And commentators were amazed she didn’t collapse before their eyes. A crowd of 15,000 Republican partisans cheered wildly. The American public doesn’t watch substance. So, therefore she hit a home run.
>> Read the StoryInVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference
nVitria, a leading global supplier of animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry, announced its Sponsorship of Cambridge Healthtech Institute’s 4th Annual “Optimizing Cell Culture Development” Conference on September 15-16 in Boston, Massachusetts.
>> Read the StoryNew Stem Cell Screening Tool Takes Adult Stem Cell Research To New Level
Stem cell research is the next great leap in medicine. In the future, new tissue grown in a laboratory could replace a failing heart, or new cells take the place of damaged cells in the brain.
>> Read the StoryApplied Biosystems Teams With Leaders in Connecticut and New Jersey to Drive Stem Cell Research
Scientists conducting stem cell research are convening at symposia in mid-September in Connecticut and New Jersey to share best practices, drive standardization to advance science, and enable greater collaboration.
>> Read the StoryHuman Stem Cell Methods Featured In CSH Protocols
The use of human embryonic stem cells is opening new avenues for research, from the understanding of normal human development to the treatment of a wide variety of diseases.
>> Read the StoryStem Cell Center Moving Ahead
Plans to build a center that would bring together the area’s top stem cell researchers in one facility on land across from UCSD are entering another phase with the release of a draft report on the project.
>> Read the StoryResearchers Tout Need for All Forms of Stem Cell Research
In light of a recent breakthrough study in adult stem cell research published in Nature, a group of the world’s leading researchers, the International Society for Stem Cell Research (ISSCR), cautions against discounting the potential benefits of all forms of stem cell research, adult and embryonic alike.
>> Read the StoryScience Questions for Would-Be Presidents
No one has ever complained that U.S. presidential candidates talk too much about science, and this year has been no exception. Nevertheless, science-related issues such as energy and health care, once viewed as sideshows, have taken center stage in this election. The candidates’ positions are often vague, but they are an improvement on past campaigns. Here are some follow-up questions that they invite.
>> Read the StoryObama Answers Scientists’ Questions
Barack Obama has proved that politicians do sometimes listen to scientists. The Democratic presidential candidate last week penned his answers to 14 science questions posed by a consortium of scientific organisations. By the end of 2007, over 38,000 Americans, including Nobel laureates and organisations such as the American Association for the Advancement of Science, had signed on to Science Debate 2008, a grass-roots initiative to spur US political debate about science and technology. Its six founders, which include Charles Darwin’s great-great grandson Matthew Chapman and creationism critic and physicist Lawrence Krauss, condensed 3400 questions down to 14 for the presidential candidates to answer.
>> Read the StoryVatican Newspaper Article Challenges “Brain Death” Notion
Debates over when life begins are by now wearily familiar, if no closer to resolution — witness Democratic presidential candidate Barak Obama’s recent comment that pegging a precise moment is “above my pay grade.”
>> Read the StoryGary Bauer: Voters are Picking a President, not a Pastor
Gary Bauer defended John McCain when I spoke with him earlier this week, even though there were several more religious outreach events at the Democratic National Convention last week than here in St. Paul. Bauer served as head of Family Research Council before he ran for president in 2000.
>> Read the StoryYoung Voters Challenge Presidential Candidates to Address Science Issues
Washington, DC: After receiving more than 1,500 entries from young people highlighting the importance of science and technology in this year’s elections, Student Pugwash USA today announced the winners of its 2008 Election Multimedia Contest for Cash.
>> Read the StoryObama Answers Science Questions Posed to Presidential Candidates
If elected president of the United States in November, Barack Obama says he will double basic science research budgets over 10 years, reduce greenhouse gas emissions by 80 percent below 1990 levels by 2050 and reach out to international partners and the private sector to extend NASA's range of Earth and space programs.
>> Read the StoryNCSU Offers Bone Marrow Transplants for Dogs
N.C. State University is about to become the first university in the country to offer bone marrow transplants for dogs with lymphoma.
>> Read the StoryTwo Synthetic Molecules Developed to Induce Stem Cell Differentiation
A group of scientists designed two molecules, EC19 and EC23, that can be used to trigger stem cell differentiation. They found that these molecules are more stable than the naturally occurring molecule currently used to induce stem cells to differentiate in the laboratory – All-trans-retinoic Acid (ATRA).
>> Read the StoryScientists Heralding Stem Cell Development
A breakthrough in stem cell technology is expected to speed vital drug development and help reduce the number of animals used in laboratory research.
>> Read the StoryObama Promises National Tech Officer and a Space Advisor to the President
Want to know what presidential candidate Barack Obama will do to make the U.S. a great nation for science again?
>> Read the Story“Knockout” Rats Could Aid Study of Psychiatric Illness
Techniques pioneered 20 years ago to make “knockout” mice — animals genetically engineered so that they lack a specific gene — can at last be applied to rats.
>> Read the StoryExercise Reduces Damage after Therapeutic Irradiation to the Brain
Researchers at the Sahlgrenska Academy in Gothenburg show for the first time that exercise helps restore stem cell growth and improves behavior in young mice that suffered damage to the brain induced by a clinically relevant dose of radiation.
>> Read the StoryJill Porter: Bristol Palin’s Frightening “Distraction”
I beg to differ with the scolds who are criticizing the media for focusing on Bristol Palin’s out-of-wedlock pregnancy. And I beg to differ with pundits who claim that the controversy is a distraction from more important issues.
>> Read the StoryScience is Politics
No, this isn’t some post-modernist rant on the inherent non-objectivity of science. On the contrary — this is a much simpler, grittier point, that science actually is the most accurate way of describing reality, and because of this, politics (the job of manipulating and controlling group’s social reality) and science will always be roommates.
>> Read the StoryStem Cells Hold Hope for Childhood Disease
Children with the often deadly motor neuron disease known as spinal muscular atrophy (SMA) may one day benefit from stem cell transplantation.
>> Read the StoryParaplegic Men Hand-cycling across Canada for Cure that Could Help Them Walk Again
Deputy Mayor Stu MacFadyen has put out a plea to all Charlottetown citizens to donate 30 cents each to fund research that could help paraplegics walk again.
>> Read the StoryTucson Foundation Urges Parents to Save Umbilical Cord
Did you ever think that a newborn’s umbilical cord could be a potential cure for a disease? Current research at the University of Arizona shows that stem cells from cord blood might one day repair a number of medical conditions. But cords are thrown away everyday and there’s a Tucson foundation that’s trying to change that — the Save the Cord Foundation.
>> Read the StoryEuropean Research Funding Caught in Ethical Controls
European Union generosity in supporting biotech research is being qualified by persistent concessions to the diversity of ethical views across the EU’s 27 member states.
>> Read the StoryStem Cell Sciences Announces the Creation of the World’s First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
Stem Cell Sciences, a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem (ES) cells in rats using technologies exclusively licensed to the company by Edinburgh University.
>> Read the StoryIt’s Palin’s Party, Not McCain’s
Sarah Palin says she is “proud” that her 17-year-old daughter, who is five months pregnant, has made a “decision to have her baby.”
>> Read the StoryObama Answers Your Science Questions
America asked Barack Obama about science, and Obama answered. “This is the first time we know of that a candidate for president has laid out his science policy before the election at this level of detail,” said Shawn Otto, CEO of ScienceDebate2008.
>> Read the StoryYounger Voters are Suspicious of the GOP
They look at the party and they see a lack of integrity — even for politics.
>> Read the StoryDeafness Research UK Excited About Gene Therapy Breakthrough
Research published this week in the journal Nature gives millions of deaf and hard of hearing people new hope of new gene or drug treatments for deafness and has been welcomed as a significant breakthrough by the country’s only medical research charity for deaf people, Deafness Research UK.
>> Read the StoryOf Mice and Medicine
Five days a week, Charles “Chip” Hawkins plays God. He peers down into a microscope and with his left hand twists a lever that holds a mouse embryo in place.
>> Read the StoryGood Immune System, Bad Stem Cell Reaction?
The core of the immune system issue is a basic but serious one; if the body will reject and destroy the injected stem cells, all of their potential benefits are moot.
>> Read the StoryGOP Platform Emphasizes Issues, Plays Down McCain
Republicans are set to ratify a party platform next week that includes sharp reversals from 2004 on hot-button issues like immigration, and makes scant reference to Senator John McCain.
>> Read the StoryIran Makes Liver Tissue from Stem Cells
Iranian scientists have successfully used a 3-dimensional nano structure to convert bone marrow stem cells into healthy liver cells.
>> Read the StoryObama on Science and Technology
On Saturday, ScienceDebate2008 and Scientists and Engineers for America announced that Barack Obama answered a fourteen-part questionnaire that they put together along with several other scientifically oriented organizations.
>> Read the StorySecond Madison Stem Cell Bank Opens in August
Madison became home to a second stem cell bank in August, and the facility will offer new stem cell lines with technology developed at University of Wisconsin.
>> Read the StoryInjections of Hope
A vast human experiment is afoot. And no one is taking good notes.
>> Read the StoryLifebank Reports Record Profitabilty in Fiscal 2008
Lifebank Corp. is pleased to announce that it has filed its audited financial statements for the year ended May 31, 2008.
>> Read the StoryAcurian Expands Performance-Based Pricing to Patient Recruitment Advertising Campaigns
Acurian, Inc., a leading provider of patient recruitment solutions, announced today that has expanded its risk-sharing patient recruitment model to include advertising-based strategies.
>> Read the StoryBoston Scientific Reports Encouraging Results from Heart Stent Trial
Boston Scientific has reported encouraging one-year data from its Syntax trial comparing percutaneous coronary intervention using the Taxus Express2 paclitaxel-eluting coronary stent system to contemporary coronary artery bypass graft surgery.
>> Read the StoryThreshold Pharmaceuticals Completes $18 Million Private Equity Financing
Threshold Pharmaceuticals, Inc., today announced that its previously announced private placement of Threshold common stock and warrants received shareholder approval and has been completed.
>> Read the StoryOptimer Pharmaceuticals Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial
Optimer Pharmaceuticals, Inc. today announced that the company has completed enrollment in the second of two planned phase 3 clinical trials evaluating the safety and efficacy of Prulifloxacin for the treatment of infectious diarrhea in travelers.
>> Read the StoryGOP Seeks Unity as Party of Mavericks
Republicans are embracing John McCain as their presidential candidate by declaring themselves mavericks but at the same time calling for unity on most issues.
>> Read the StoryPotent Promise: Back to the Womb
Stem cells’ powers of self-renewal, immortality and potential for medicine inspire those who study them. But progress toward understanding them has been slow — it took 20 years just to figure out how to grow embryonic stem cells in the laboratory.
>> Read the StorySarah Palin on Faith, Life and Creation
John McCain’s vice-presidential pick, Alaska Gov. Sarah Palin, is an evangelical Protestant with a strong record of opposition to abortion and an openness to teaching creationism in the public schools.
>> Read the StoryLeerink Swann Lowers Revenue Estimate, Cuts Price Target on Helicos’ Stock
Investment bank Leerink Swann has cut its 12-month price target for Helicos BioSciences’ stock to $6 from $10 and has roughly halved its revenue estimates for the firm for fiscal years 2008-2010.
>> Read the StoryPancreatic Cells Converted Into Insulin-Maker Cells
The Harvard University biologists have turned cells from mouse pancreas tissue into insulin-producing ones that are destroyed in diabetes, The New York Times reported.
>> Read the StoryVet with his Head in the Clouds
Pete Anderson climbs into his Piper Pawnee and takes off into a vast blue Marlborough sky.
>> Read the StoryToday the Index Value closed at $1.47, down -0.02 -- a loss of -1.34%.
The index value dropped to 0.4038 from 0.4093 with an associated index market cap of $1.203 Billion.
| Company | Ticker | Last | Change | % |
| Advanced Cell Technology | ACTC.OB | $0.00 | $0.00 | 0 |
| Aastrom Biosciences | ASTM | $0.32 | -$0.0298 | -8.52% |
| AVI Biopharma | AVII | $1.17 | $0.02 | 1.74% |
| BrainStorm Cell Therapeutics | BCLI.OB | $0.26 | $0.00 | 0.00 |
| CRYO-CELL International | CCEL.OB | $0.80 | $0.12 | 17.65% |
| Cytori Therapeutics | CYTX | $6.41 | -$0.10 | -1.54% |
| Geron Corporation | GERN | $4.45 | -$0.23 | -4.91% |
| ThermoGenesis | KOOL | $1.66 | -$0.02 | -1.19% |
| MultiCell Technologies | MCET.OB | $0.00 | -$0.0008 | -16.00% |
| NeoStem, Inc. | NEOI.OB | $0.00 | $0.00 | 0 |
| Opexa Therapeutics Inc. | OPXA | $2.01 | -$0.1199 | -5.63% |
| Osiris Therapeutics, Inc. | OSIR | $15.47 | $0.18 | 1.18% |
| Ortec International, Inc. | OTCI.OB | $0.00 | $0.00 | 0 |
| Stem Cell Thera | SSS.V | $0.14 | $0.005 | 3.70% |
| StemCells | STEM | $1.18 | $0.01 | 0.85% |
| ViaCell | VIAC | $0.00 | $0.00 | 0 |
Last Close: Sep 4, 2008 17:15:01 PDT
This week's events
BioPharm America 2008
September 9, 2008Atlanta, Georgia
German Conference on Bioinformatics 2008
September 9, 2008Dresden, Germany
View All:
> Stem Cells Events
> Personalized Medicine Events
> Clinical Trials Events
Advertisement
